See more : Enomoto Co.,Ltd. (6928.T) Income Statement Analysis – Financial Results
Complete financial analysis of Grapefruit USA, Inc. (GPFT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Grapefruit USA, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Softline Holding PLC (SFTL.IL) Income Statement Analysis – Financial Results
- Hangzhou Huaxing Chuangye Communication Technology Co., Ltd. (300025.SZ) Income Statement Analysis – Financial Results
- PT Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk (JMAS.JK) Income Statement Analysis – Financial Results
- China Mengniu Dairy Company Limited (2319.HK) Income Statement Analysis – Financial Results
- SpaceandPeople plc (SAL.L) Income Statement Analysis – Financial Results
Grapefruit USA, Inc. (GPFT)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.grapefruitblvd.com
About Grapefruit USA, Inc.
Grapefruit USA, Inc. operates as a manufacturer and distributor of cannabis products in California. It primarily provides Hourglass, a time release THC+CBD-infused topical cream through online store. The company was formerly known as Grapefruit Boulevard Investments, Inc. and changed its name to Grapefruit USA, Inc. in January 2020. Grapefruit USA, Inc. was founded in 2017 and is based in Wilmington, Delaware.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 200.00 | 39.79K | 588.96K | 3.67M | 451.20K | 181.50K | 41.83K | 33.08K | 220.81K | 398.27K | 1.05M | 1.05M | 1.07M | 1.18M | 1.36M | 1.76M | 1.32M | 1.39M | 2.10M | 1.28M |
| Cost of Revenue | 237.11K | 504.03K | 1.12M | 3.39M | 708.57K | 183.46K | 14.26K | 10.25K | 169.12K | 163.14K | 585.79K | 585.79K | 505.87K | 532.16K | 700.25K | 662.23K | 910.13K | 676.62K | 1.07M | 638.11K |
| Gross Profit | -236.91K | -464.25K | -530.17K | 280.47K | -257.37K | -1.96K | 27.57K | 22.84K | 51.69K | 235.14K | 466.75K | 466.75K | 562.75K | 645.32K | 664.64K | 1.09M | 413.65K | 709.32K | 1.02M | 642.55K |
| Gross Profit Ratio | -118,456.00% | -1,166.86% | -90.02% | 7.64% | -57.04% | -1.08% | 65.90% | 69.03% | 23.41% | 59.04% | 44.34% | 44.34% | 52.66% | 54.81% | 48.70% | 62.28% | 31.25% | 51.18% | 48.81% | 50.17% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 2.40K | 108.79K | 200.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 1.78M | 1.32M | 1.62M | 6.32M | 1.65M | 2.70M | 1.50M | 1.36M | 1.86M | 1.86M | 0.00 | 2.47M | 2.51M | 2.28M | 2.47M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 7.66K | 169.35K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 688.91K | 1.73M | 1.79M | 1.49M | 1.62M | 6.32M | 1.65M | 2.70M | 1.50M | 1.36M | 1.86M | 1.86M | 2.95M | 2.47M | 2.51M | 2.28M | 2.47M | 2.75M | 1.63M | 1.92M |
| Other Expenses | 0.00 | 0.00 | 371.32K | 169.35 | 0.00 | -23.33K | 87.49K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 688.91K | 1.73M | 1.79M | 1.49M | 1.62M | 6.32M | 1.65M | 2.70M | 1.50M | 1.36M | 1.86M | 1.86M | 2.95M | 2.47M | 2.51M | 2.28M | 2.47M | 3.01M | 2.18M | 2.66M |
| Cost & Expenses | 926.02K | 2.23M | 2.91M | 4.88M | 2.33M | 6.32M | 1.67M | 2.71M | 1.67M | 1.52M | 2.45M | 2.45M | 3.45M | 3.00M | 3.21M | 2.94M | 3.38M | 3.69M | 3.25M | 3.30M |
| Interest Income | 0.00 | 0.00 | 1.68K | 2.10K | 571.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.11M | 1.47M | 1.68M | 2.10M | 571.05K | 679.69K | 1.17M | 2.89M | 1.19M | 6.06K | -975.99K | 975.99K | 423.37K | 55.15K | 52.37K | 51.79K | 70.86K | 68.78K | 85.84K | 78.12K |
| Depreciation & Amortization | 186.72K | 73.61K | 741.60K | 171.06K | 63.98K | 24.71K | 3.40M | 1.00 | 0.00 | 0.00 | 0.00 | 7.57K | 10.52K | 7.82K | -3.10K | 17.91K | 15.23K | 14.62K | 15.23K | 16.39K |
| EBITDA | -549.06K | -2.23M | -3.08M | -1.21M | -3.96M | -243.61K | 4.03M | -3.87M | -1.44M | -1.11M | -6.51M | 3.62M | -17.49M | -4.14M | -1.86M | -836.43K | -2.05M | -2.29M | -1.14M | -2.00M |
| EBITDA Ratio | -274,528.00% | -5,330.14% | -110.77% | -28.19% | -401.68% | -3,495.76% | -3,680.43% | -8,084.79% | -657.31% | -281.19% | -132.57% | -131.85% | -222.14% | -154.04% | -135.15% | -66.48% | -158.52% | -164.31% | -29.14% | -111.43% |
| Operating Income | -925.82K | -2.19M | -2.42M | -1.21M | -1.88M | -6.32M | -1.63M | -2.67M | -1.45M | -1.12M | -1.40M | -1.40M | -2.38M | -1.92M | -1.93M | -1.19M | -2.05M | -2.30M | -1.16M | -2.02M |
| Operating Income Ratio | -462,911.00% | -5,515.16% | -410.14% | -32.85% | -415.86% | -3,482.91% | -3,889.59% | -8,084.79% | -657.31% | -281.19% | -132.57% | -132.57% | -223.13% | -163.16% | -141.24% | -67.50% | -154.99% | -165.95% | -55.19% | -157.44% |
| Total Other Income/Expenses | -924.14K | -1.58M | -3.09M | -2.85M | -2.72M | 5.96M | 4.48M | -4.09M | -1.18M | 524.00 | -5.13M | 4.03M | -15.54M | -2.28M | 16.45K | 279.07K | -8.81K | 178.83K | -62.13K | 99.89K |
| Income Before Tax | -1.85M | -3.78M | -5.51M | -4.06M | -4.60M | -8.13M | 2.85M | -6.76M | -2.63M | -1.12M | 800.00 | 2.64M | -17.93M | -4.20M | -1.91M | -906.13K | -2.06M | -2.12M | -1.22M | -1.92M |
| Income Before Tax Ratio | -924,981.50% | -9,492.70% | -934.71% | -110.47% | -1,019.42% | -4,478.93% | 6,821.37% | -20,435.48% | -1,191.81% | -281.06% | 0.08% | 250.56% | -1,677.49% | -356.68% | -140.03% | -51.61% | -155.65% | -153.05% | -58.16% | -149.64% |
| Income Tax Expense | 2.00 | 0.00 | 1.68M | -753.70 | 580.52K | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 |
| Net Income | -1.85M | -3.78M | -7.19M | -4.06M | -5.18M | -8.13M | 2.85M | -6.76M | -2.63M | -1.12M | 2.64M | 2.64M | -17.93M | -4.20M | -1.91M | -906.93K | -2.06M | -2.12M | -1.22M | -1.92M |
| Net Income Ratio | -924,981.50% | -9,492.70% | -1,220.69% | -110.47% | -1,148.08% | -4,479.37% | 6,819.46% | -20,437.90% | -1,192.18% | -281.26% | 250.49% | 250.49% | -1,677.56% | -356.75% | -140.09% | -51.65% | -155.71% | -153.10% | -58.19% | -149.70% |
| EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.04 | -0.25 | 0.21 | -0.64 | -0.29 | -0.15 | 0.02 | 0.20 | -0.91 | -0.22 | -0.13 | -0.07 | -0.19 | -0.22 | -0.14 | -0.25 |
| EPS Diluted | 0.00 | -0.01 | -0.01 | -0.01 | -0.04 | -0.25 | 0.18 | -0.64 | -0.29 | -0.15 | 0.02 | 0.07 | -0.91 | -0.22 | -0.13 | -0.07 | -0.19 | -0.22 | -0.14 | -0.25 |
| Weighted Avg Shares Out | 901.40M | 670.66M | 515.34M | 498.23M | 140.04M | 32.12M | 13.83M | 10.64M | 9.20M | 7.49M | 149.75M | 25.00M | 19.63M | 18.84M | 14.73M | 12.18M | 10.60M | 9.72M | 8.53M | 7.76M |
| Weighted Avg Shares Out (Dil) | 901.40M | 670.66M | 515.34M | 498.23M | 140.04M | 32.12M | 15.67M | 10.64M | 9.20M | 7.49M | 149.75M | 37.50M | 19.63M | 18.84M | 14.73M | 12.18M | 10.60M | 9.72M | 8.53M | 7.76M |
Canna-Biotech Co. Grapefruit USA Signs Term Sheet With Dubai-Based Lender To Build GPFT 'Mothership'
California-based canna-biotech company Grapefruit USA, Inc. (OTCQB:GPFT) has executed a term sheet with the Al Habtoor Group, located in Dubai, UAE, to finance development of its 2-acre lot in the Coachillin' Canna-Business Park in Desert Hot Springs, California, located just...
Grapefruit USA, Inc. Announces Expanded Agreement with Canadian Firms Medz Cannabis and 6PAK Solutions to Shepherd Grapefruit's Patented Hourglass™ Time Release THC+CBD Delivery Cream Through Health Canada's Regulatory Process
LOS ANGELES and DESERT HOT SPRINGS, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), a premiere California-based cannabis and hemp company, is pleased to announce it has entered into...
Grapefruit USA, Inc. Acquires Controlling Interest in Summit Boys, Inc. of Monterey, Calif., in Stock-for-Stock Exchange
LOS ANGELES and DESERT HOT SPRINGS, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), a premiere, fully licensed California-based cannabis company, today announces that on Friday, Sept. 10, 2021,...
Grapefruit USA, Inc. Issues Further Update Concerning Formation of Joint Venture with Canadian Partner to Distribute Hourglass Products in Canada, Possible Acquisition
LOS ANGELES and DESERT HOT SPRINGS, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), a premiere, fully licensed California-based cannabis company, today provides further updates to its March and...
Grapefruit Clarifies Potential Ramifications of Senate Majority Leader Schumer's Push to Federally Legalize Cannabis
LOS ANGELES and DESERT HOT SPRINGS, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Grapefruit USA, Inc., (“GPFT,” “Grapefruit” or the “Company”) (OTCQB: GPFT), a California based cannabis company, today sets forth its position on the potential enactment of...
Captor Capital's California Retail Cannabis Dispensaries to Carry Grapefruit's Patented Hourglass THC/CBD Delivery Cream
LOS ANGELES, July 06, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), a premiere California-based cannabis and hemp company, is pleased to announce that Captor Capital Corp. (CSE: CPTR.CN; Frankfurt NMVA; Stuttgart...
Grapefruit USA, Inc. Announces New Strategic Alliance with 6PAK Solutions Canada to Shepherd Grapefruit's Patented Hourglass™ Time Release THC+CBD Delivery Cream through Health Canada's Regulatory Requirements
LOS ANGELES and DESERT HOT SPRINGS, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), a premiere California-based cannabis and hemp company, is pleased to announce it has signed a...
Grapefruit USA, Inc. Expands Its Hemp Based CBD Products with a New USDA Certified Organic CBD Pet Tincture
LOS ANGELES and DESERT HOT SPRINGS, Calif., June 14, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Grapefruit USA, Inc., (“GPFT,” “Grapefruit” or the “Company”) (OTCQB: GPFT), a California based hemp and cannabis company, announces today that it is expanding its hemp-based...
Grapefruit USA, Inc. Issues Update Concerning the Company's Progress Through the First Five Months of 2021
LOS ANGELES and DESERT HOT SPRINGS, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), a premiere, fully licensed California-based cannabis and hemp Company, is updating the public with respect...
Grapefruit USA Retains Premier Investor Relations and Communications Marketing Firm SRAX to Raise Its Brand Awareness
LOS ANGELES and DESERT HOT SPRINGS, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Grapefruit USA, Inc., (“GPFT,” “Grapefruit” or the “Company”) (OTCQB: GPFT) a California based hemp and cannabis company, announces that it has engaged investor relations...
Source: https://incomestatements.info
Category: Stock Reports